Evaluation of Prostate Enlargement Surgery to Patients and Determining their Quality of Life and Resulting Complications

Background and Aim: The onset of benign prostatic hyperplasia (BPH) and the ensuing Lower Urinary Tract Symptoms (LUTS) are significantly predicted by age. The present study aims to evaluate the clinical outcomes before and after prostatic urethral lift surgery in patients with prostate enlargement. Methods: A total of 103 patients diagnosed with benign prostatic hyperplasia (BPH) were treated with prostatic urethral lift (PUL) In several hospitals in Iraq over the course of a one-year follow-up period, commencing in April 2023 and concluding in April 2024. The PUL procedure was performed on male patients aged 45-72 years. A comprehensive set of surgical and clinical data were meticulously recorded for each patient, encompassing various parameters such as surgical duration, mortality, morbidity, complications, pain rates, and the assessment of patients' quality of life following PUL surgery. Results: Our study showed that the most common symptoms in patients were difficulty initiating urination (33.01%) and urgency (14.56%). Prostate volume was 54.5 ± 3.8 ml, International Prostate Symptom Score (IPSS) was 21.2 ± 2.8, and maximum urinary flow rate was 5.6 ± 0.4 before surgery. Surgical results: Our results showed that the urethral elevation of the prostate at the time of surgery was 28.5 ± 4.9, the number of implants included 2.0 ± 0.4, the length of hospital stay was 2.1 ± 1.7 days, intraoperative complications were 13.59% of patients, postoperative complications were 10.68%, the most prominent of which was dysuria, which included three cases, IPSS (postoperative) was 4.5 ± 3.2, improved urination included 96.12%, and improved sexual function included 87.38%. Conclusion: In Iraq, a safe and efficient therapy for BPH is a prostate urethral lift. This procedure may be performed using local anesthetic, is fewer invasive, and can be suitable for people who are easily agitated